MBGFX
Price
$21.62
Change
+$0.22 (+1.03%)
Updated
Sep 4 closing price
Net Assets
2.16B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
332.38B
Interact to see
Advertisement

MBGFX vs RGEBX

Header iconMBGFX vs RGEBX Comparison
Open Charts MBGFX vs RGEBXBanner chart's image
MassMutual Blue Chip Growth R4
Price$21.62
Change+$0.22 (+1.03%)
VolumeN/A
Net Assets2.16B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets332.38B
MBGFX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MBGFX vs. RGEBX commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBGFX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. MBGFX (2.16B). MBGFX (0.00) and RGEBX (0.00) have matching dividends . MBGFX was incepted earlier than RGEBX: MBGFX (11 years) vs RGEBX (11 years). MBGFX (1.10) and RGEBX (1.09) have similar cost to investors . RGEBX is a more actively managed with annual turnover of: 25.00 vs. MBGFX (11.00). RGEBX has a lower initial minimum investment than MBGFX: RGEBX (250) vs MBGFX (1000). RGEBX annual gain was more profitable for investors over the last year : 17.59 vs. MBGFX (8.67). RGEBX return over 5 years is better than : 38.71 vs. MBGFX (-20.36).
MBGFXRGEBXMBGFX / RGEBX
Total Expense Ratio1.101.09101%
Annual Report Gross Expense Ratio1.101.09101%
Fund Existence11 years11 years-
Gain YTD11.89015.39877%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets2.16B332B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year8.6717.5949%
Returns for 3 years18.4157.6132%
Returns for 5 years-20.3638.71-53%
Returns for 10 years28.5091.4431%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
DNLI15.430.64
+4.33%
Denali Therapeutics
FRPH25.47-0.03
-0.12%
FRP Holdings
CNA48.01-0.94
-1.92%
CNA Financial Corp
PMAX0.26-0.03
-9.59%
Powell Max Ltd